Diabetes mellitus
A recent spate of studies from the United Kingdom and Japan has shed new light on various aspects of diabetes management and the underlying factors influencing glucose regulation. Researchers in both countries have made significant discoveries, ranging from the impact of injection timing for exenatide to the effect of thorough
Drugs
Quinapril treatment has been shown to significantly improve insulin-stimulated endothelial function and glucose metabolism in patients with type 2 diabetes. According to a study by T.S. Hermann and colleagues from Bispebjerg University Hospital, a 2-month course of quinapril treatment increased insulin-stimulated endothelial function in type 2 diabetic patients. This
Drugs
Recent studies from the United States and Canada have shed new light on the relationship between obesity, cardiac function, and leptin. Research has shown that leptin-deficient and leptin-resistant mice experience increased apoptosis, DNA damage, and mortality compared to their wild-type counterparts. Furthermore, studies have found that leptin induces rat glomerular
Drugs
PR Pharmaceuticals Inc. (PRP) has successfully secured a U.S. patent for 2-methoxyestradiol (2ME), a compound that has demonstrated significant potential in treating diabetes and pulmonary arterial hypertension (PAH). The patent, assigned to the University of Pittsburgh, has been exclusively licensed to PRP, which is developing the drug, known as
Drugs
CytRx Corp. (CYTR) has made significant strides in its drug-discovery programs aimed at developing molecular medicines for obesity and type 2 diabetes using its proprietary RNA interference (RNAi) technologies. The company's high-throughput functional RNAi screening platform has discovered and validated approximately 30 new type 2 diabetes and obesity
Drugs
Scientists in Japan have conducted a study to investigate the effect of consuming pork-liver protein hydrolysate (PLH) on body fat accumulation in obese rats. The research, led by M. Shimizu and colleagues working with the Nippon Meat Packers, involved feeding male 20-week-old Otsuka Long-Evans Tokushima Fatty (OLETF) rats and Long-Evans
Drugs
Research from Japan, the Canada V6T 1Z3, and the United Kingdom has led to significant advances in diabetes therapy, with new findings on the efficacy and safety of various treatments. Key studies have shown that novel drugs such as KCP256 and dipeptidyl peptidase IV inhibitors can effectively manage diabetes without
Endocrinology
Researchers in France have found that aldosterone receptor antagonists can prevent cardiovascular disease and nephropathy in diabetic patients. The study, published in Diabetes and Metabolism, suggests that these molecules can be used to prevent or treat end-organ damage, particularly in patients with heart failure, diabetic nephropathy, and certain forms of
Endocrinology
Diabetic mice exhibit resistance to prostaglandin D2 synthase inhibition of cell cycle progression and migration of vascular smooth muscle cells. Recent research has shed light on the regulation of vascular smooth muscle cell proliferation, migration, and apoptosis, highlighting its role in the atherosclerotic process. Scientists in the United States have
Diabetes mellitus
Recent research from Denmark has shed light on the effects of experimental diabetes on calcitonin gene-related peptide-expressing primary sensory neurons. According to a study published in Diabetes, the absolute numbers of immunoreactive substance P and calcitonin gene-related peptide (CGRP) dorsal root ganglion (DRG) cell bodies were estimated in diabetic and
Diabetes mellitus
Research conducted by scientists at the Hagedorn Research Institute in Denmark has shed light on the initial events leading to the activation of the immune system in type 1 diabetes. The team generated transgenic mice expressing CD154 on pancreatic beta cells and observed that these mice developed both insulitis and
Endocrinology
Type 1 diabetes research has been a focal point in the scientific community, particularly regarding the role of vitamin D in modulating the immune system. Recent studies have suggested that vitamin D administration may reduce the risk of type 1 diabetes, but the exact mechanisms and gene sequence variants involved
